Related Experiment Video
Updated: Mar 3, 2026

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
Published on: January 31, 2022
Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound iron
Deborah Stefanova1, Antoan Raychev2, Joao Arezes3
1Molecular, Cellular, and Integrative Physiology Graduate Program and.
Abstract:
The iron-regulatory hormone hepcidin is induced early in infection, causing iron sequestration in macrophages and decreased plasma iron; this is proposed to limit the replication of extracellular microbes, but could also promote infection with macrophage-tropic pathogens. The mechanisms by which hepcidin and hypoferremia modulate host defense, and the spectrum of microbes affected, are poorly understood. Using mouse models, we show that hepcidin was selectively protective against siderophilic extracellular pathogens (Yersinia enterocolitica O9) by controlling non-transferrin-bound iron (NTBI) rather than iron-transferrin concentration. NTBI promoted the rapid growth of siderophilic but not nonsiderophilic bacteria in mice with either genetic or iatrogenic iron overload and in human plasma. Hepcidin or iron loading did not affect other key components of innate immunity, did not indiscriminately promote intracellular infections (Mycobacterium tuberculosis), and had no effect on extracellular nonsiderophilic Y enterocolitica O8 or Staphylococcus aureus Hepcidin analogs may be useful for treatment of siderophilic infections.
Insights
The hormone hepcidin protects against siderophilic bacteria by controlling non-transferrin-bound iron (NTBI). This finding suggests hepcidin analogs could treat specific bacterial infections.
Area of Science:
- Immunology
- Microbiology
- Hematology
Background:
- The iron-regulatory hormone hepcidin influences host defense during infection by sequestering iron.
- The precise mechanisms and microbial targets of hepcidin-mediated immunity remain unclear.
- Hepcidin's role in modulating iron availability for microbial pathogens requires further investigation.
Purpose of the Study:
- To elucidate the mechanisms by which hepcidin and hypoferremia impact host defense against diverse microbial pathogens.
- To determine the specific role of non-transferrin-bound iron (NTBI) in bacterial growth during infection.
- To assess the potential therapeutic applications of hepcidin modulation for infectious diseases.
Main Methods:
- Utilized mouse models of infection to study hepcidin's effects on host defense.
- Investigated the impact of hepcidin and iron overload on the growth of various bacterial species, including siderophilic and nonsiderophilic pathogens.
- Analyzed the role of non-transferrin-bound iron (NTBI) versus transferrin-bound iron in supporting bacterial replication.
Main Results:
- Hepcidin conferred selective protection against siderophilic extracellular bacteria (Yersinia enterocolitica O9) by regulating NTBI levels.
- Non-transferrin-bound iron significantly promoted the rapid growth of siderophilic bacteria in iron-overloaded conditions and human plasma.
- Hepcidin modulation and iron loading did not broadly enhance intracellular infections (Mycobacterium tuberculosis) or affect nonsiderophilic extracellular bacteria (Y. enterocolitica O8, Staphylococcus aureus).
Conclusions:
- Hepcidin's protective effect against certain bacterial infections is mediated through the control of non-transferrin-bound iron.
- Non-transferrin-bound iron is a critical factor supporting the proliferation of siderophilic pathogens.
- Hepcidin analogs represent a potential therapeutic strategy for treating infections caused by siderophilic bacteria.
More Related Videos
09:05High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability
Published on: November 21, 2014
08:45Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
Published on: May 10, 2022
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
The Early Endosome: Endocytosis of Transferrin
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
Most drugs undergo restrictive clearance, which is proportional to the...
Transduction
Development of Antibiotic Resistance